Clinical Trials Directory

Trials / Terminated

TerminatedNCT02750384

Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects

An Assessment of the Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Medicines for Malaria Venture · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is a single-dose, fasting and non-fasting, open-label, randomized, three-regimen, parallel group study in 42 subjects

Detailed description

This is a randomized, open label, single dose, parallel group study consisting of 3 groups of 14 subjects each. Subjects will be confined for 3 days followed by outpatient assessments until Day 21. Blood samples for assessment of DSM265 plasma concentrations will be collected for 480 hours after dosing. This study will compare the relative bioavailability of the oral DSM265 50% spray dried dispersion (SDD) granules with that of a reference 25% SDD powder for suspension formulation, and evaluate the effect of food on the DSM265 50% SDD granules

Conditions

Interventions

TypeNameDescription
DRUGDSM265 50% SDD granulesSingle oral dose 400 mg
DRUGDSM265 25% SDD powder for suspensionSingle oral dose 400 mg

Timeline

Start date
2016-05-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-04-25
Last updated
2016-09-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02750384. Inclusion in this directory is not an endorsement.